FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Getinge/Maquet Recalls VasoView HemoPro 2 Devices

Getinge and its subsidiary Maquet Cardiovascular recall the VasoView HemoPro 2 (VH-4000 and VH-4001) Endoscopic Vessel Harvesting Systems due to the p...

latest-news-card-1
Federal Register

23 No-Longer-Marketed Generics Withdrawn

Federal Register notice: FDA withdraws approval of 23 ANDAs from multiple applicants after they told the agency that the drug products were no longer ...

latest-news-card-1
Human Drugs

Vanda Can Seek Tradipitant Hearing: FDA Notice

FDA proposes to deny a Vanda NDA for tradipitant and offers the company an opportunity to seek a commissioners hearing on the denial.

latest-news-card-1
Medical Devices

7 QS Issues at 3 Integra Facilities

FDA warns Integra Lifesciences about Quality System Regulation violations in the manufacturing of neurological and neurosurgical medical devices at th...

latest-news-card-1
Medical Devices

Hologic QS and MDR Violations

FDA warns Marlborough, MA-based Hologic about Quality System and Medical Device Reporting violations in its production of implantable radiographic mar...

latest-news-card-1
Federal Register

Novo Nordisk Wins Priority Review Voucher

Federal Register notice: FDA issues Novo Nordisk a priority review voucher for gaining approval for its hemophilia drug Alhemo (concizumab-mtci) last ...

latest-news-card-1
Federal Register

12 No-Longer-Marketed NDAs Withdrawn

Federal Register notice: FDA withdraws the approval of 12 NDAs from multiple applicants because they are no longer marketed.

latest-news-card-1
Human Drugs

OIG Faults 3 of 24 FDA Accelerated Approvals

The HHS Inspector General raises concerns about three of 24 drugs approved through the FDA accelerated approval pathway.

latest-news-card-1
Human Drugs

Nitrosamine CPCA Expedites Drug Approvals: FDA

FDA says a new method of determining an acceptable intake limit for nitrosamine impurities in drugs that it helped to develop has expedited regulatory...

latest-news-card-1
Human Drugs

ANDA Oligonucleotide Guides Needed: AAM

The Association for Accessible Medicines calls on FDA to produce several guidances for generic oligonucleotide drugs.